Cargando…
Toxicity and Immunogenicity of a Tardigrade Cytosolic Abundant Heat Soluble Protein in Mice
Tardigrades are microscopic animals well-known for their stress tolerance, including the ability to survive desiccation. This survival requires cytosolic abundant heat soluble (CAHS) proteins. CAHS D protects enzymes from desiccation- and lyophilization-induced inactivation in vitro and has the pote...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7577191/ https://www.ncbi.nlm.nih.gov/pubmed/33117164 http://dx.doi.org/10.3389/fphar.2020.565969 |
_version_ | 1783598151903477760 |
---|---|
author | Esterly, Harrison J. Crilly, Candice J. Piszkiewicz, Samantha Shovlin, Dane J. Pielak, Gary J. Christian, Brooke E. |
author_facet | Esterly, Harrison J. Crilly, Candice J. Piszkiewicz, Samantha Shovlin, Dane J. Pielak, Gary J. Christian, Brooke E. |
author_sort | Esterly, Harrison J. |
collection | PubMed |
description | Tardigrades are microscopic animals well-known for their stress tolerance, including the ability to survive desiccation. This survival requires cytosolic abundant heat soluble (CAHS) proteins. CAHS D protects enzymes from desiccation- and lyophilization-induced inactivation in vitro and has the potential to stabilize protein-based therapeutics, including vaccines. Here, we investigate whether purified recombinant CAHS D causes hemolysis or a toxic or immunogenic response following intraperitoneal injection in mice. CAHS D did not cause hemolysis, and all mice survived the 28-day monitoring period. The mice gained weight normally and developed anti-CAHS D antibodies but did not show upregulation of the inflammatory cytokines interleukin-6 and tumor necrosis factor alpha. In summary, CAHS D is not toxic and does not promote an inflammatory immune response in mice under the conditions used here, suggesting the reasonability of further study for use as stabilizers of protein-based therapeutics. |
format | Online Article Text |
id | pubmed-7577191 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-75771912020-10-27 Toxicity and Immunogenicity of a Tardigrade Cytosolic Abundant Heat Soluble Protein in Mice Esterly, Harrison J. Crilly, Candice J. Piszkiewicz, Samantha Shovlin, Dane J. Pielak, Gary J. Christian, Brooke E. Front Pharmacol Pharmacology Tardigrades are microscopic animals well-known for their stress tolerance, including the ability to survive desiccation. This survival requires cytosolic abundant heat soluble (CAHS) proteins. CAHS D protects enzymes from desiccation- and lyophilization-induced inactivation in vitro and has the potential to stabilize protein-based therapeutics, including vaccines. Here, we investigate whether purified recombinant CAHS D causes hemolysis or a toxic or immunogenic response following intraperitoneal injection in mice. CAHS D did not cause hemolysis, and all mice survived the 28-day monitoring period. The mice gained weight normally and developed anti-CAHS D antibodies but did not show upregulation of the inflammatory cytokines interleukin-6 and tumor necrosis factor alpha. In summary, CAHS D is not toxic and does not promote an inflammatory immune response in mice under the conditions used here, suggesting the reasonability of further study for use as stabilizers of protein-based therapeutics. Frontiers Media S.A. 2020-10-07 /pmc/articles/PMC7577191/ /pubmed/33117164 http://dx.doi.org/10.3389/fphar.2020.565969 Text en Copyright © 2020 Esterly, Crilly, Piszkiewicz, Shovlin, Pielak and Christian http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Pharmacology Esterly, Harrison J. Crilly, Candice J. Piszkiewicz, Samantha Shovlin, Dane J. Pielak, Gary J. Christian, Brooke E. Toxicity and Immunogenicity of a Tardigrade Cytosolic Abundant Heat Soluble Protein in Mice |
title | Toxicity and Immunogenicity of a Tardigrade Cytosolic Abundant Heat Soluble Protein in Mice |
title_full | Toxicity and Immunogenicity of a Tardigrade Cytosolic Abundant Heat Soluble Protein in Mice |
title_fullStr | Toxicity and Immunogenicity of a Tardigrade Cytosolic Abundant Heat Soluble Protein in Mice |
title_full_unstemmed | Toxicity and Immunogenicity of a Tardigrade Cytosolic Abundant Heat Soluble Protein in Mice |
title_short | Toxicity and Immunogenicity of a Tardigrade Cytosolic Abundant Heat Soluble Protein in Mice |
title_sort | toxicity and immunogenicity of a tardigrade cytosolic abundant heat soluble protein in mice |
topic | Pharmacology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7577191/ https://www.ncbi.nlm.nih.gov/pubmed/33117164 http://dx.doi.org/10.3389/fphar.2020.565969 |
work_keys_str_mv | AT esterlyharrisonj toxicityandimmunogenicityofatardigradecytosolicabundantheatsolubleproteininmice AT crillycandicej toxicityandimmunogenicityofatardigradecytosolicabundantheatsolubleproteininmice AT piszkiewiczsamantha toxicityandimmunogenicityofatardigradecytosolicabundantheatsolubleproteininmice AT shovlindanej toxicityandimmunogenicityofatardigradecytosolicabundantheatsolubleproteininmice AT pielakgaryj toxicityandimmunogenicityofatardigradecytosolicabundantheatsolubleproteininmice AT christianbrookee toxicityandimmunogenicityofatardigradecytosolicabundantheatsolubleproteininmice |